Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,813 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
Kawahara A, Azuma K, Sumi A, Taira T, Nakashima K, Aikawa E, Abe H, Yamaguchi T, Takamori S, Akiba J, Kage M. Kawahara A, et al. Among authors: nakashima k. Lung Cancer. 2011 Oct;74(1):35-40. doi: 10.1016/j.lungcan.2011.02.002. Epub 2011 Mar 27. Lung Cancer. 2011. PMID: 21444121
The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer.
Kawahara A, Azuma K, Hattori S, Nakashima K, Basaki Y, Akiba J, Takamori S, Aizawa H, Yanagawa T, Izumi H, Kohno K, Kono S, Kage M, Kuwano M, Ono M. Kawahara A, et al. Among authors: nakashima k. Hum Pathol. 2010 Jul;41(7):951-9. doi: 10.1016/j.humpath.2009.12.007. Epub 2010 Mar 17. Hum Pathol. 2010. PMID: 20236686
Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.
Kawahara A, Yamamoto C, Nakashima K, Azuma K, Hattori S, Kashihara M, Aizawa H, Basaki Y, Kuwano M, Kage M, Mitsudomi T, Ono M. Kawahara A, et al. Among authors: nakashima k. Clin Cancer Res. 2010 Jun 15;16(12):3163-70. doi: 10.1158/1078-0432.CCR-09-3239. Epub 2010 Apr 27. Clin Cancer Res. 2010. PMID: 20423982
Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations.
Yamamoto C, Basaki Y, Kawahara A, Nakashima K, Kage M, Izumi H, Kohno K, Uramoto H, Yasumoto K, Kuwano M, Ono M. Yamamoto C, et al. Among authors: nakashima k. Cancer Res. 2010 Nov 1;70(21):8715-25. doi: 10.1158/0008-5472.CAN-10-0043. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959484
Nuclear β-catenin expression in basal cell adenomas of salivary gland.
Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K, Mihashi H, Akiba J, Kage M. Kawahara A, et al. Among authors: nakashima k. J Oral Pathol Med. 2011 Jul;40(6):460-6. doi: 10.1111/j.1600-0714.2011.01010.x. Epub 2011 Feb 16. J Oral Pathol Med. 2011. PMID: 21323741
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment.
Azuma K, Okamoto I, Kawahara A, Taira T, Nakashima K, Hattori S, Kinoshita T, Takeda M, Nakagawa K, Takamori S, Kuwano M, Ono M, Kage M. Azuma K, et al. Among authors: nakashima k. J Thorac Oncol. 2012 Jan;7(1):122-7. doi: 10.1097/JTO.0b013e31822eeba2. J Thorac Oncol. 2012. PMID: 21892099 Free article.
2,813 results